Literature DB >> 9365885

Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non-risk populations.

C M Nübling1, H Bialleck, A J Fürsch, I Scharrer, W Schramm, E Seifried, U Schmidt, S Staszewski, J Löwer.   

Abstract

The prevalence of the new flavivirus GB virus C/hepatitis virus G (GBV-C/HGV) in different German populations was investigated by detection of viral genomes and anti-E2 antibodies. While blood donors had an overall prevalence of 10.4% there were increased rates for hemophiliacs (54.7%), hemodialysis patients (30.2%), male homosexuals (30.2%) and intravenous drug users (74.4). Most GBV-C/HGV positive samples were either viral genome positive or antibody positive, exclusively. Samples with the rare constellation "positive for both GBV-C/HGV genome and specific antibody" originated in almost all cases from patients who were additionally infected with HIV or HCV. Probable transmission of GBV-C/HGV by PCR-positive blood transfusions was observed in 5 of 6 cases approximately six months after transfusion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365885

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

Review 1.  GB virus C/hepatitis G virus (GBV-C/HGV): still looking for a disease.

Authors:  M Sathar; P Soni; D York
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

2.  GB virus C Viremia and Anti-E2 Antibody Response Among Hemodialysis Patients in Gorgan, Iran.

Authors:  Mishar Kelishadi; Mohammad Mojerloo; Abdolvahab Moradi; Masoud Bazouri; Pezhman Hashemi; Sobhan Samadi; Atefeh Saeedi; Alijan Tabarraei
Journal:  Jundishapur J Microbiol       Date:  2014-11-01       Impact factor: 0.747

Review 3.  Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication.

Authors:  Yaqi Yu; Zhenzhou Wan; Jian-Hua Wang; Xianguang Yang; Chiyu Zhang
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.